Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ENDOMETRIAL NEOPLASMS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00005840
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer

Who this might be right for
Endometrial Clear Cell AdenocarcinomaEndometrial Serous AdenocarcinomaStage III Uterine Corpus Cancer+1 more
Gynecologic Oncology Group 35
Large-scale testing (Phase 3)Study completedNCT01376349
What this trial is testing

Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms

Who this might be right for
Breast CancerGynecologic Cancer
Alliance for Clinical Trials in Oncology 464
Not applicableUnknownNCT02512848
What this trial is testing

The Feasibility Study of the Li Brush for the Screening of Endometrial Cancer in the Postmenopausal Period

Who this might be right for
Endometrial Neoplasms
First Affiliated Hospital Xi'an Jiaotong University 100
Not applicableUnknownNCT02822833
What this trial is testing

The Role of Indocyanine Green to Identify Sentinel Lymph Node in Uterine Cancer

Who this might be right for
Endometrial Neoplasm
Ankara University 100
Testing effectiveness (Phase 2)Study completedNCT00004915
What this trial is testing

Raloxifene in Treating Patients With Persistent or Recurrent Endometrial Cancer

Who this might be right for
Endometrial Cancer
Northwestern University
Not applicableLooking for participantsNCT03438474
What this trial is testing

Endometrial Cancer Lymphadenectomy Trial

Who this might be right for
Cancer of Endometrium Stage ICancer of Endometrium Stage II
Philipps University Marburg 640
Testing effectiveness (Phase 2)Ended earlyNCT05180474
What this trial is testing

GEN1047 for Solid Tumors - First in Human (FIH) Trial

Who this might be right for
Breast Cancer, Breast NeoplasmsEndometrial Cancer, Endometrial NeoplasmOvarian Cancer, Ovarian Neoplasms+1 more
Genmab 179
Testing effectiveness (Phase 2)UnknownNCT01234818
What this trial is testing

Management of Endometrial Hyperplasia With a LNG-IUS: Multicenter Study: KGOG2006

Who this might be right for
Endometrial Hyperplasia
Korean Gynecologic Oncology Group 80
Not applicableStudy completedNCT06623916
What this trial is testing

Strain-elastography in Endometrial Cancer

Who this might be right for
Endometrial Cancer
Alper seyhan 63
Testing effectiveness (Phase 2)Study completedNCT04491643
What this trial is testing

Megestrol Acetate Plus Rosuvastatin in Young Women With Early Endometrial Carcinoma

Who this might be right for
Endometrial Carcinoma Stage I
Fudan University 48
Very early researchStudy completedNCT03018249
What this trial is testing

Medroxyprogesterone Acetate With or Without Entinostat Before Surgery in Treating Patients With Endometrioid Endometrial Cancer

Who this might be right for
FIGO Grade 1 Endometrial Endometrioid AdenocarcinomaFIGO Grade 2 Endometrial Endometrioid AdenocarcinomaFIGO Grade 3 Endometrial Endometrioid Adenocarcinoma
National Cancer Institute (NCI) 50
Large-scale testing (Phase 3)Not Yet RecruitingNCT05524389
What this trial is testing

Study of Early Stage Endometrial Cancer Based on Molecular Classification and Traditional Risk Stratification to Guide Adjuvant Radiotherapy Decisions

Who this might be right for
Endometrial CancerAdjuvant RadiotherapyMolecular Classification
Peking Union Medical College Hospital 624
Not applicableUnknownNCT06341855
What this trial is testing

Exploring the Potential of ctDNA-MRD for Recurrence Surveillance and Prognostic Evaluation in High-risk Endometrial Cancer

Who this might be right for
Endometrial Cancer
The First Hospital of Jilin University 100
Testing effectiveness (Phase 2)UnknownNCT00492778
What this trial is testing

Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer

Who this might be right for
Endometrial Endometrioid Adenocarcinoma, Variant With Squamous DifferentiationEndometrial Mucinous AdenocarcinomaEndometrial Squamous Cell Carcinoma+5 more
GOG Foundation 165
Testing effectiveness (Phase 2)Study completedNCT01011933
What this trial is testing

Selumetinib in Treating Patients With Recurrent or Persistent Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Adenosquamous CarcinomaEndometrial Clear Cell Adenocarcinoma+1 more
National Cancer Institute (NCI) 54
Early research (Phase 1)Active Not RecruitingNCT04188548
What this trial is testing

LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer

Who this might be right for
Breast CancerAdvanced Breast CancerMetastatic Breast Cancer+1 more
Eli Lilly and Company 379
Not applicableUnknownNCT03838055
What this trial is testing

Sentinel Node Detection in Endometrial Cancer: A Consolidation Study on Detection Rates of Metastatic Disease

Who this might be right for
Sentinel Lymph NodeEndometrial CancerLymphedema
Region Skane 362
Testing effectiveness (Phase 2)Looking for participantsNCT07303387
What this trial is testing

Efficacy and Safety of the Valemetostat in Patients With Selected Solid Tumors.

Who this might be right for
Solid Tumor MalignanciesClear Cell Endometrial CarcinomaOvarian Cancer
Gustave Roussy, Cancer Campus, Grand Paris 900
Testing effectiveness (Phase 2)Study completedNCT05634499
What this trial is testing

Giredestrant in Participants With Grade 1 Endometrial Cancer

Who this might be right for
Endometrial Cancer
Hoffmann-La Roche 33
Early research (Phase 1)Study completedNCT01138085
What this trial is testing

Safety, Pharmacokinetics (PK) of AKT and MEK Combination

Who this might be right for
Cancer
GlaxoSmithKline 240
Next Page